Kawasaki Motors Corp., U.S.A.
Summary
NHTSA campaign 22V397: Kawasaki Motors Corp., U.S.A. recalled for a safety defect. Reduced brake performance can increase the risk of a crash.
Details
Source
nhtsa
External ID
22V397
Action Date
2022-06-07
Status
Ongoing
Category
vehicle
Product Description
Kawasaki Motors Corp., U.S.A. (KMC) is recalling certain 2020-2021 LX230A and 2022 LX230G motorcycles. The incorrect front brake rotor may have been installed, which can reduce brake performance. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 122, "Motorcycle Brake Systems."
Context & Analysis
Kawasaki Motors Corp., U.S.A. has 17 FDA actions in our database.
Frequently Asked Questions
How often does Kawasaki Motors Corp., U.S.A. have FDA actions?
Kawasaki Motors Corp., U.S.A. has 17 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle